Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel anticancer TLR7 agonists disclosed

June 14, 2012

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

June 14, 2012

Novel agents for migraine prepared at Merck & Co.

June 14, 2012

Synta Pharmaceuticals prepares new IL-2/CRAC-targeted products

June 13, 2012

New PI3K inhibitors developed in U.S.

June 13, 2012

Merck & Co. reports new CGRP receptor antagonists

June 13, 2012

Novel diagnostics disclosed by Janssen Pharmaceuticals

June 13, 2012

Bristol-Myers Squibb patents novel inhibitors of CYP17

June 13, 2012

Roche presents novel LRRK2 inhibitors

June 13, 2012

New ENTPD5 inhibitors developed by University of Texas System

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...